Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2007
10/24/2007CN101057936A Fat-smoothing capsule and its preparation method
10/24/2007CN101057916A Traditional Chinese medicine composition for lowering blood-lipid, and method for preparing the same
10/24/2007CN101057908A Heart and brain health dispersion tablet and its preparation method
10/24/2007CN101057900A Biological calcium capsule and its preparation method
10/24/2007CN101057888A Traditional Chinese medicinal composition for regulating immunity and its preparation method and application
10/24/2007CN101057878A Pomegranate rind extraction and its preparation method
10/24/2007CN101057867A Calcium replenishing agent with made of oyster shell, clam shell and egg shell with citric acid reaction
10/24/2007CN101057849A Slow-releasing preparation containing metformin hydrochloride and glipizide and its preparation method
10/24/2007CN101057847A Polyhydroxy piperidines compound and preparation method and application thereof
10/24/2007CN101057838A Medicine for preventing and/or curing hyperlipidemia
10/24/2007CN101057693A Double embryo beverage
10/24/2007CN101057678A Composition containing natural plant extraction or monomer
10/24/2007CN101057677A 新禧营养素增补剂 Sun Hey nutrient supplements
10/24/2007CN101057675A Health-care food capable of auxiliary reducing blood sugar and its preparing process
10/24/2007CN101057674A Composition for preventing and curing diabetes
10/24/2007CN101057667A Method for low temperature forced extracting bamboo juice
10/24/2007CN101057661A Extraction method for alpha-linolenic acid and preparation
10/24/2007CN101057643A Rice with blood sugar reducing function
10/24/2007CN101057640A Fine dried noodles containing chromium, glossy ganoderma and carrot and its processing method
10/24/2007CN101057616A Recuperating tea
10/24/2007CN101057614A Heat-clearing eyesight-improving bowels-relaxing health tea
10/24/2007CN101057613A Heat-clearing and antitoxic heart-soothing and sedative tea
10/24/2007CN100344957C Method for measuring total flavone content in compositions extracted from gingko biloba leaves
10/24/2007CN100344648C Cyclosporine analogue mixtures and their use as immunomodulating agents
10/24/2007CN100344646C Oligonucleotide-containing pharmacological compositions and their use
10/24/2007CN100344632C 稠合的呋喃化合物 Fused furan compound
10/24/2007CN100344618C N-benzyl acryloyl substituted tyrosine derivatives as hPPAR alpha and hPPAR gamma agonist
10/24/2007CN100344616C Compounds for the treatment of metabolic disorders
10/24/2007CN100344326C Iron-supplementing preparation
10/24/2007CN100344323C Human glucagon-like peptide-1 compound and its preparing method
10/24/2007CN100344300C Cyclodextrin super molecular composition of Chinese medicine giant knutweed rhizome and its preparing method
10/24/2007CN100344289C Pollen pini soft capsule and its preparation method
10/24/2007CN100344286C Slow controlled released combsn. preparation of semisolid framework of containing glipizide
10/24/2007CN100344278C Lasofoxifene tablet and its coating
10/24/2007CN100344238C Method for producing sugar-reducing soluble granules richly containing alpha-linolenic acid, lecithin and trivalent chromium
10/23/2007US7285681 Biguanide derivatives
10/23/2007US7285680 β-alanine derivatives and the use thereof
10/23/2007US7285666 Pyrazolo[1,5-a] pyridines and medicines containing the same
10/23/2007US7285664 Heterocyclic or benzenic derivatives of lipoic acid, their preparation and their use as medicaments
10/23/2007US7285642 Composition and method for modulating dendritic cell-T cell interaction
10/23/2007US7285572 Compounds as for example, 2'-[1-[(2R)-3-[[1-(3-fluoro-4-methylphenyl)-2-methylpropan-2-yl]amino]-2-hydroxypropoxy]ethyl]-3-methylbiphenyl-4-carboxylic acid, having a calcium-sensing receptor antagonistic action; therapeutic drug for osteoporosis
10/23/2007US7285562 Derivatives of 2-mercaptobenzothiazole, 2-mercaptobenzoxazole, 2-mercaptothiazolo[5,4-b]pyridine, or 2-mercaptooxazolo[5,4-b]pyridine; cardiovascular disorders, diabetes, cancer and obesity
10/23/2007US7285560 E.g., N-[(S)-2-diphenylamino-1-(5-oxo-4,5-dihydro[1,3,4]oxadizol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide; used for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarction, Alzheimer's diseases, cancer diseases or atherosclerosis
10/23/2007US7285549 Sulfamides and their use as endothelin receptor antagonists
10/23/2007US7285543 Purine inhibitors of fructose-1,6-bisphosphatase
10/23/2007US7285535 Administering TIRAP to block Toll/Interleukin-1 Receptor Adaptor Protein signaling in a cell; for treatment of inflammation and inducing or affecting immune response.
10/23/2007US7285525 Suppression of immune response via inhibition of cathepsin S
10/23/2007US7285298 Use of a dihydrochalcone-rich phenolic fraction in a cosmetic treatment
10/23/2007US7285293 Isolating modulators of amyloid expression; obtain plant, extract proteins, incubate with chromatographic column, elute, recover preferential protein
10/23/2007CA2391098C Recombinant .alpha.-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
10/18/2007WO2007117563A2 1.alpha.-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds and methods of making and use thereof
10/18/2007WO2007117022A1 Chewing composition comprising coenzyme q10
10/18/2007WO2007116981A1 Fat accumulation inhibitor
10/18/2007WO2007116980A1 Suppressor of increase in blood glucose level
10/18/2007WO2007116916A1 Liquid drug preparation for oral administration
10/18/2007WO2007116731A1 Composition containing reduced coenzyme a
10/18/2007WO2007116579A1 Lypolysis promoter
10/18/2007WO2007116230A1 Azetidine derivatives as g-protein coupled receptor (gpr119 ) agonists
10/18/2007WO2007116100A1 Condensed imidazole derivatives as aromatase inhibitors
10/18/2007WO2007116097A1 Condensed imidazole derivatives as aldosterone synthase inhibitors
10/18/2007WO2007116091A1 Novel nutraceutical compositions
10/18/2007WO2007115973A2 Food products for hypophosphoric normo-, hyper- and hypoproteic diets, and their use for nutrition of subjects in need of a low phosphorus level diet
10/18/2007WO2007115938A1 5-amido-2-carboxamide indoles
10/18/2007WO2007115935A1 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ACTIVE COMPOUNDS
10/18/2007WO2007115821A2 Organic compounds
10/18/2007WO2007115820A1 Chromen-2-one derivatives
10/18/2007WO2007115798A1 Substituted phenylpiperidine derivatives as melanocortin-4 receptor modulators
10/18/2007WO2007115473A1 Pyrrole derivatives inhibitors, their curative uses
10/18/2007WO2007100880A8 Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors
10/18/2007WO2007100561A3 Use of dha and ara in the preparation of a composition for preventing or treating obesity
10/18/2007WO2007071038A3 Compositions comprising one or more phytosterols and/or phytostanols, or derivatives thereof, and high hlb emulsifiers
10/18/2007WO2007057849B1 2,3,4,5-tetrahydroxy-6-sulfooxyhexanoic acid and its metal salts for medical use
10/18/2007US20070244198 Carboxylic Derivatives
10/18/2007US20070244184 Glycosidase inhibitors and methods of synthesizing same
10/18/2007US20070244172 Compounds for the treatment of metabolic disorders
10/18/2007US20070244171 Compounds for the treatment of metabolic disorders
10/18/2007US20070244141 Compounds for the treatment of metabolic disorders
10/18/2007US20070244139 Indole Derivatives or Benzimidazole Derivatives for Modulating IkB Kinase
10/18/2007US20070244109 1-{3-[(6-amino-5-nitropyridin-2-yl)amino]propyl}-4-(2,4-dichlorophenyl)-N-[(1S)-2-hydroxy-1-methylethyl]-1H-pyrrole-3-carboxamide; Antidiabetic, hypotensive, antiischemic, anticarcinogenic agents; Alzheimer*s disease, obesity, polycystic ovary syndrome; brain, neurodegenerative and autoimmune diseases
10/18/2007US20070244108 Phenylsulfonamide Derivatives for Use as 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors
10/18/2007US20070244047 Albumin fusion proteins
10/18/2007US20070243268 Compositions for regulating intestinal disorders and methods of use thereof
10/18/2007US20070243231 Use of Whey Permeate for the Treatment of Metabolic Syndrome
10/18/2007US20070243211 Compositions for regulating metabolic disorders and methods of use thereof
10/18/2007CA2649214A1 Condensed imidazole derivatives as aromatase inhibitors
10/18/2007CA2648687A1 Azetidine derivatives as g-protein coupled receptor (gpr119 ) agonists
10/18/2007CA2648653A1 Fat accumulation inhibitor
10/18/2007CA2648335A1 Substituted phenylpiperidine derivatives as melanocortin-4 receptor modulators
10/18/2007CA2648324A1 2-methylene-1.alpha.,25-dihydroxy-19,21-dinorvitamin d3 analogs and uses thereof
10/18/2007CA2648193A1 1.alpha.-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds and methods of making and use thereof
10/18/2007CA2648172A1 Drugs and food products for hypophosphoric normo-, hyper- and hypoproteic diets, and hypophosphoric beverages
10/18/2007CA2648074A1 11.beta.-hydroxysteroid dehydrogenase type 1 active compounds
10/18/2007CA2647440A1 5-amido-2-carboxamide indoles
10/18/2007CA2644951A1 Chromen-2-one derivatives
10/18/2007CA2643659A1 Organic compounds
10/17/2007EP1845106A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction
10/17/2007EP1845105A1 Modified exendins and uses thereof
10/17/2007EP1845095A1 1-thio-d-glucitol derivatives
10/17/2007EP1845092A1 Pyrimidinone compounds, their preparation and use thereof
10/17/2007EP1845081A1 Amide compound
1 ... 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 ... 1298